Literature DB >> 15109581

Alpha-synuclein, Parkinson's disease, and Alzheimer's disease.

Seonghan Kim1, Ji-Heui Seo, Yoo-Hun Suh.   

Abstract

Alpha synuclein (alpha-SN) is a ubiquitous protein that is especially abundant in the brain and has been postulated to play a central role in the pathogenesis of Parkinson's disease (PD), Alzheimer's disease, and other neurodegenerative disorders. Here, we show that alpha-SN plays dual role of neuroprotection and neurotoxicity depending on its concentration or level of expression. In addition, our study shows that alpha-synuclein is differentially expressed in human peripheral blood mononuclear cells. PD patients expressed more alpha-synuclein than healthy controls. Thus, the alpha-synuclein expression in the peripheral immune system might be one of the primary causes of immune abnormalities in PD patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15109581     DOI: 10.1016/j.parkreldis.2003.11.005

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  19 in total

1.  Interferon-γ Potentiates α-Synuclein-induced Neurotoxicity Linked to Toll-like Receptors 2 and 3 and Tumor Necrosis Factor-α in Murine Astrocytes.

Authors:  Jintang Wang; Zheng Chen; Jeremy D Walston; Peisong Gao; Maolong Gao; Sean X Leng
Journal:  Mol Neurobiol       Date:  2019-05-16       Impact factor: 5.590

2.  The Role of Alpha-Synuclein Autoantibodies in the Induction of Brain Inflammation and Neurodegeneration in Aged Humans.

Authors:  Manoj Kumar Pandey
Journal:  Front Aging Neurosci       Date:  2022-05-26       Impact factor: 5.702

3.  Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants.

Authors:  Cintia Roodveldt; Adahir Labrador-Garrido; Elena Gonzalez-Rey; Rafael Fernandez-Montesinos; Marta Caro; Christian C Lachaud; Christopher A Waudby; Mario Delgado; Christopher M Dobson; David Pozo
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

4.  α-Synuclein activates innate immunity but suppresses interferon-γ expression in murine astrocytes.

Authors:  Jintang Wang; Zheng Chen; Jeremy D Walston; Peisong Gao; Maolong Gao; Sean X Leng
Journal:  Eur J Neurosci       Date:  2018-05-19       Impact factor: 3.386

5.  NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.

Authors:  Rachael H Earls; Kelly B Menees; Jaegwon Chung; Claire-Anne Gutekunst; Hyun Joon Lee; Manuel G Hazim; Balázs Rada; Levi B Wood; Jae-Kyung Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-03       Impact factor: 11.205

6.  Blood genome-wide transcriptional profiles reflect broad molecular impairments and strong blood-brain links in Alzheimer's disease.

Authors:  Bartholomew J Naughton; F Jason Duncan; Darren A Murrey; Aaron S Meadows; David E Newsom; Nicoleta Stoicea; Peter White; Douglas W Scharre; Douglas M Mccarty; Haiyan Fu
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

7.  Postmortem Interval Influences α-Synuclein Expression in Parkinson Disease Brain.

Authors:  Alexandra Dumitriu; Carlee Moser; Tiffany C Hadzi; Sally L Williamson; Christopher D Pacheco; Audrey E Hendricks; Jeanne C Latourelle; Jemma B Wilk; Anita L Destefano; Richard H Myers
Journal:  Parkinsons Dis       Date:  2012-03-13

Review 8.  Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson's disease and beyond.

Authors:  Jae Ryul Bae; Byoung Dae Lee
Journal:  BMB Rep       Date:  2015-05       Impact factor: 4.778

Review 9.  Immunological features of alpha-synuclein in Parkinson's disease.

Authors:  Cintia Roodveldt; John Christodoulou; Christopher M Dobson
Journal:  J Cell Mol Med       Date:  2008-07-30       Impact factor: 5.310

10.  Protein expression profiling during chick retinal maturation: a proteomics-based approach.

Authors:  Sorcha Finnegan; Joanne L Robson; Mildred Wylie; Adrienne Healy; Alan W Stitt; William J Curry
Journal:  Proteome Sci       Date:  2008-12-10       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.